Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Grande

Showing results (21-30 of 202) with videos related to

Pageof 21
Sort By:
Clinical Kidney Journal|December 12, 2017
Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of diseaseMiroslav Sekulic, Samih H Nasr, Joseph P Grande, et al.
Nutrition and Cancer|April 5, 2011
Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumorsSoner Dogan, Anna C Johannsen, Joseph P Grande, et al.
Scientific Reports|June 5, 2019
Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate CancerSangphil Oh, Sook Shin, Hoogeun Song, et al.
Nutrition and Cancer|December 30, 2004
Diet-induced obesity and mammary tumor development in MMTV-neu female miceMargot P Cleary, Joseph P Grande, Subhash C Juneja, et al.
The American Journal of Medicine|May 4, 2005
Incidence and prognosis of acute heart failure in the thrombotic microangiopathiesApoor S Gami, Suzanne R Hayman, Joseph P Grande, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?James V Donadio, Eric J Bergstralh, Douglas M Bibus, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2001
A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathyJames V Donadio, Timothy S Larson, Erik J Bergstralh, et al.
American Journal of Physiology. Renal Physiology|April 29, 2011
Genetic deficiency of Smad3 protects against murine ischemic acute kidney injuryKarl A Nath, Anthony J Croatt, Gina M Warner, et al.
American Journal of Physical Medicine & Rehabilitation|December 21, 2012
The physiatrists' crucial role in the development and implementation of a longitudinal musculoskeletal physical examination curriculum in a medical schoolKaren L Newcomer, Edward R Laskowski, Joseph P Grande, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathyJames V Donadio, Erik J Bergstralh, Joseph P Grande, et al.
Pageof 21

Showing results (21-30 of 202) with videos related to

Sort By:
Pageof 21
Clinical Kidney Journal|December 12, 2017
Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of diseaseMiroslav Sekulic, Samih H Nasr, Joseph P Grande, et al.
Nutrition and Cancer|April 5, 2011
Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumorsSoner Dogan, Anna C Johannsen, Joseph P Grande, et al.
Scientific Reports|June 5, 2019
Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate CancerSangphil Oh, Sook Shin, Hoogeun Song, et al.
Nutrition and Cancer|December 30, 2004
Diet-induced obesity and mammary tumor development in MMTV-neu female miceMargot P Cleary, Joseph P Grande, Subhash C Juneja, et al.
The American Journal of Medicine|May 4, 2005
Incidence and prognosis of acute heart failure in the thrombotic microangiopathiesApoor S Gami, Suzanne R Hayman, Joseph P Grande, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?James V Donadio, Eric J Bergstralh, Douglas M Bibus, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2001
A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathyJames V Donadio, Timothy S Larson, Erik J Bergstralh, et al.
American Journal of Physiology. Renal Physiology|April 29, 2011
Genetic deficiency of Smad3 protects against murine ischemic acute kidney injuryKarl A Nath, Anthony J Croatt, Gina M Warner, et al.
American Journal of Physical Medicine & Rehabilitation|December 21, 2012
The physiatrists' crucial role in the development and implementation of a longitudinal musculoskeletal physical examination curriculum in a medical schoolKaren L Newcomer, Edward R Laskowski, Joseph P Grande, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathyJames V Donadio, Erik J Bergstralh, Joseph P Grande, et al.
Pageof 21